Related Experiment Videos
[Renal angiomyolipoma: benign tumor?]
Y Tuchschmid1, J F Bolle, P Graber
1Département de Chirurgie, Hôpital cantonal universitaire, Genève, Suisse.
Journal D'Urologie
|January 1, 1991
Summary
Angiomyolipoma (AML), a benign kidney tumor, can cause severe bleeding and flank pain due to fragile vessels. Early diagnosis via imaging is crucial for managing this condition and preventing complications.
Area of Science:
- Nephrology
- Oncology
- Radiology
Background:
- Angiomyolipoma (AML) is a benign renal neoplasm.
- Vascular fragility in AML can lead to significant hemorrhage.
- Diagnosis relies on characteristic imaging findings.
Purpose of the Study:
- To review clinical data, investigations, and treatments for angiomyolipoma.
- To highlight the potential morbidity associated with AML.
- To discuss diagnostic modalities for renal AML.
Main Methods:
- Retrospective review of angiomyolipoma cases from 1979 to 1991.
- Analysis of clinical presentation, diagnostic imaging (ultrasound, CT scan), and treatment outcomes.
- Evaluation of patient data regarding morbidity.
Main Results:
- Angiomyolipoma can present incidentally or with acute flank pain due to hemorrhage.
- Ultrasound typically shows a hyperechogenic mass.
- CT scan reveals a mass with partially negative density.
Conclusions:
- Despite being benign, angiomyolipoma carries a risk of high morbidity.
- Prompt diagnosis and appropriate management are essential.
- Understanding AML's clinical behavior is key to patient care.